期刊文献+

北京市某社区男性迟发性性腺功能减退的关联因素分析

Correlation analysis of late-onset hypogonadism in a community in Beijing
原文传递
导出
摘要 目的探讨男性迟发性性腺功能减退的关联因素。方法该研究为横断面研究。纳入2023年2月6日至6月30日在北京市海淀区羊坊店社区卫生服务中心参加健康体检的40~75岁男性居民,筛选出迟发性性腺功能减退(LOH)的患者作为LOH组,并按年龄匹配对照组。收集入选者的一般临床资料。抽取入选者空腹静脉血,完善一般健康体检项目的同时测定总睾酮、性激素结合球蛋白水平,并计算游离睾酮水平。通过汉化的老年男性症状量表(AMS)评定相关症状。采用多因素logistic回归模型分析LOH的关联因素。结果满足入排标准并获得知情同意的社区男性居民共233人,其中诊断为LOH者42例(18.03%)。按年龄进行匹配,LOH组和对照组各入选40人,年龄分别为(64.8±6.0)和(62.3±8.6)岁。多因素logistic回归分析结果显示,糖尿病和血脂异常与LOH呈独立正向关联(分别为OR=4.497,95%CI:1.291~15.664,P=0.018;OR=8.431,95%CI:1.566~45.405,P=0.013),而血红蛋白水平与LOH呈独立负向关联(OR=0.923,95%CI:0.874~0.975,P=0.004)。结论血脂异常、糖尿病与LOH呈独立正向关联,血红蛋白水平与LOH呈独立负向关联。 Objective To investigate the factors associated with late-onset hypogonadism(LOH)in men.Methods This was a cross-sectional study.Male residents aged 40-75 years who attended health examinations at the Yangfangdian Community Health Service Center in Haidian District,Beijing from February 6th to June 30th,2023 were included.The LOH group was selected based on diagnostic criteria and matched to the control group according to age.General clinical data were collected from both groups,fasting venous blood samples were taken and general health examination items were completed.Total testosterone(TT)and sex hormone-binding globulin(SHBG)levels were measured,and free testosterone(fT)were calculated.Relevant symptoms were assessed using the Chinese version of the Aging Males′Symptoms(AMS)scale.Single and multiple factor comparative analyses were conducted to explore the factors related to LOH.Results A total of 233 male residents from the community who met the inclusion criteria and gave informed consent were included,of whom 42 cases(18.03%)were diagnosed with LOH.After age matching,the final LOH and control groups consisted of 40 individuals each((64.8±6.0)years vs.(62.3±8.6)years,P>0.05).There were statistically significant differences between the LOH and control groups for body mass index,waist circumference,sex hormone-binding globulin,AMS scores,and hemoglobin.The prevalence of diabetes and dyslipidemia was significantly higher in the LOH group than in the control group(both P<0.05).Multivariate logistic regression analysis showed that diabetes(OR=4.497,95%CI:1.291-15.664,P=0.018),dyslipidemia(OR=8.431,95%CI:1.566-45.405,P=0.013),and hemoglobin level(OR=0.923,95%CI:0.874-0.975,P=0.004)were significantly associated with LOH.Conclusion Diabetes,dyslipidemia and hemoglobin levels are significantly associated with LOH.
作者 陈锐 张晶 张明燕 Chen Rui;Zhang Jing;Zhang Mingyan(Department of General Practice,Beijing Shijitan Hospital Affiliated to Capital Medical University,Beijing 100038,China;Yangfangdian Community Health Service Center,Haidian District,Beijing 100038,China)
出处 《中华全科医师杂志》 2024年第7期716-721,共6页 Chinese Journal of General Practitioners
基金 首都医科大学附属北京世纪坛医院青年基金(2020-q20)。
关键词 男性迟发性性腺功能减退症 高血压 血脂异常 血红蛋白类 Late onset hypogonadism in male Hypertension Dyslipidemias Hemoglobins
  • 相关文献

参考文献8

二级参考文献50

  • 1毛剑敏,孙建明,颜广,刘鹏,韩文均,倪晨,董哲,武鹏涛,莫然.SRD5A2基因态性与迟发性性腺功能减退症相关性[J].临床军医杂志,2020(9):1103-1105. 被引量:4
  • 2申素琪,徐晓燕,蔡瑞芬,童建孙.江苏省3551例中老年男性健康调查[J].中华男科学杂志,2005,11(6):438-441. 被引量:45
  • 3Heinemann LA, Zimmermann T, Vermeulen A, et al. A new ag- ing males'symptoms (AMS) rating scale. Aging Male, 1999, 2 (2) : 105-114.
  • 4Heinemann LA, Saad F, Heinemann K, et al. Can results of the Aging Males" Symptoms (AMS) scale predict those of screening scales for androgen deficiency? Aging Male, 2004, 7 (3) : 211- 218.
  • 5Kobayashi K, Hashimoto K, Kato R, et al. The aging males" symptoms scale for Japanese men : Reliability and applicability of the Japanese version. Int J Impot Res, 2008, 20(6) : 544-548.
  • 6Daig I, Heinemann LAJ, Kim S, et al. The Aging Males'Symp- toms (AMS) scale: Review of its methodological characteristics. Health Qual Life Outcomes, 2003, 1 : 77.
  • 7Myon E, Martin N, Taieb C. The French Aging Males'Symptoms (AMS) scale: Methodological review. Health Qual Life Out- comes, 2005, 3 : 20.
  • 8Myon E, Martin N, Taieb C, et al. Experiences with the French Aging Males" Symptoms (AMS) scale. Aging Male, 2005, 8 ( 3- 4) : 184-189.
  • 9Kaplan SA,Chung DE,Lee RK,et al.A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia:Finasteride has comparable urinary symptom efficacy and prostate volume reduction,but less sexual side effects and breast complications than dutasteride.International Journal of Clinical Practice,2012,66(11):1052-1055.
  • 10Kim MK,Cheon J,Lee KS,et al.An open,non-comparative,multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia.International Journal of Clinical Practice,2010,64(3):345-350.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部